Clinical Trial Update: Risperidone LA Heathcare Resource Study [Phase 4]

View source ↗

Summary

A Phase 4 post-marketing study of risperidone long-acting injectable conducted by the University of British Columbia has completed. The study targeted patients …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psychosis
• Schizophrenia

Drugs mentioned

• Risperidone long-acting injectable (risperidone)

Snippet

Sponsor: University of British Columbia | Conditions: Psychosis, Schizophrenia | Phase 4 | Status: COMPLETED